About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) is a biopharmaceutical company focused on developing medicines to improve survival and quality of life of cancer patients. Our portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

Our people are inspired by the strength, tenacity and courage of those battling cancer. Verastem team is anchored by core values of character, urgency, respect, and excellence. We pride ourselves in being an organization committed to diversity and inclusion in order to achieve and sustain excellence.

We believe that empowering employees is what makes them truly care about the important work they do. To join our team or for more information, please visit www.verastem.com.